OBSERVATION OF CHILDREN WITH BRONCHIAL ASTHMA IN A POLYCLINIC
Main Article Content
Abstract
The aim of the research – assessment of the management of children with bronchial asthma (BA) in the outpatient practice.
Materials and methods. The analysis of 112 outpatient records of children aged from 5 to 16 years living in Novosibirsk was carried out. The average age of patients at diagnosis was 5.2 ± 0.4 years. The length of the BA experience at the time of the study averaged 5.9 ± 0.3 years. The characteristics of the course of asthma, the frequency of exacerbations, the need for hospitalization, the adequacy of the basic therapy, the level of achieved control, the atopic status of patients, the presence of comorbid allergic diseases and their impact on the course of asthma, the level of preferential drug provision, the completeness of examinations and studies were analyzed.
Results. The most frequently detected was polyvalent sensitization (77.7 %) with a predominance of sensitivity to household (43.8 %) and epidermal (39.3 %) allergens. Significant triggers of exacerbations were also non-immune factors (respiratory infections, physical activity, irritants, pollutants, emotional stress, stressful situations). Almost all patients (95.5%) were diagnosed with comorbid diseases that required therapeutic correction. Allergen-specific immunotherapy was carried out in isolated cases (6.3%), despite the presence of indications. Among patients with mild persistent asthma, only 84.8 % received basic treatment. In patients with moderate disease, basic therapy was prescribed to all, but in 20.5 % the choice of drug was irrational and did not correspond to the severity of the disease. A well-controlled course of disease was recorded in 45.5 %, partially controlled in 27.7 %, uncontrolled in 4.5 %. The medical documentation of 22.3 % of patients did not indicate the level of control, which did not allow determining further management tactics. Monitoring of the course of asthma was insufficient.
Conclusion. The reasons for insufficient management of asthma symptoms were lack of control of immune and non-immune triggers, comorbid diseases, low coverage of the allergen-specific immunotherapy, absence or irrational choice of the drugs for basic treatment.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Shakhova NV, Kashinskaya TS, Kamaltynova EM. Prevalence of bronchial asthma and allergic diseases among children. Allergology and Immunology in Pediatrics. 2022; 2: 5-12. Russian (Шахова Н.В., Кашинская Т.С., Камалтынова Е.М. Распространенность бронхиальной астмы и аллергических заболеваний среди детей //Аллергология и иммунология в педиатрии. 2022. № 2. С. 5-12.) DOI: 10.53529/2500-1175-2022-2-5-12
Asher MI, García-Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J. 2020; 56(6): 2002094. DOI: 10.1183/13993003.02094-2020
Bystritskaya EV, Bilichenko TN. The review of the bronchial asthma morbidity in the population of the Russian Federation. Pul’monologiya. 2022; 32(5): 651-660. Russian (Быстрицкая Е.В., Биличенко Т.Н. Обзор общей заболеваемости населения Российской Федерации бронхиальной астмой //Пульмонология. 2022. 32(5): 651-660.) DOI: 10.18093/0869-0189-2022-32-5-651-660
Antonov NS, Sakharova GM, Rusakova LI, Salagay OO. Dynamics of the Incidence of Respiratory Diseases Among the Population of the Russian Federation in 2010-2022. Medicine. 2023; 11(3): 1-17. Russian (Антонов Н.С., Сахарова Г.М., Русакова Л.И., Салагай О.О. Динамика заболеваемости болезнями органов дыхания среди населения Российской Федерации в 2010-2022 гг. //Медицина. 2023. Т. 11, № 3. С. 1-17.) DOI: 10.29234/2308-9113-2023-11-3-1-17
Lo D, Beardsmore C, Roland D, Richardson M, Yang Y, Danvers L, et al. Risk factors for asthma attacks and poor control in children: a prospective observational study in UK primary care. Arch Dis Child. 2022; 107(1): 26-31. DOI: 10.1136 / archdischild-2020-320110
Geppe NA, Kolosova NG, Kondyurina EG, Malakhov AB, Revyakina VA. Modern international and Russian recommendations for monitoring and treatment of bronchial asthma in children. Pediatria n.a. G.N. Speransky. 2022; 101(3): 51-57. Russian (Геппе Н.А., Колосова Н.Г., Кондюрина Е.Г., Малахов А.Б., Ревякина В.А. Современные международные и российские рекомендации по мониторированию и лечению бронхиальной астмы у детей //Педиатрия им. Г.Н. Сперанского. 2022. Т. 101, № 3. С. 51-57.) DOI: 10.24110/0031-403X-2022-101-3-51-57
Murphy KR, Hong JG, Wandalsen G, Larenas-Linnemann D, El Beleidy A, Zaytseva OV, Pedersen SE. Nebulized inhaled corticosteroids in asthma treatment in children 5 years or younger: a systematic review and global expert analysis. Allergy Clin Immunol Pract. 2020; 8(6): 1815-1827. DOI: 10.1016 /j.jaip.2020.01.042
Kolosova NG, Shakhnazarova MD. A rational approach to the treatment of bronchial asthma in children: what can we do to manage the disease? Medical Council. 2020; (1): 140-144. Russian (Колосова Н.Г., Шахназарова М.Д. Рациональный подход к терапии бронхиальной астмы у детей: что мы можем сделать для контроля заболевания? //Медицинский совет. 2020. № 1. С. 140-144.) DOI: 10.21518/2079-701X-2020-1-140-144
Surovenko TN, Glushkova EF Therapy and control of bronchial asthma in children and adolescents. Medical Council. 2020; (10): 101-107. Russian (Суровенко Т.Н., Глушкова Е.Ф. Терапия и контроль бронхиальной астмы у детей и подростков //Медицинский совет. 2020. № 10. С. 101-107.) DOI: 10.21518/2079-701X-2020-10-101-107
Khokha RN, Paramonova NS. Phenotypic features of a patient with bronchial asthma in the clinical practice of a pediatrician. Allergology and Immunology in Pediatrics. 2023; 2: 60-62. Russian (Хоха Р.Н, Парамонова Н.С. Фенотипические особенности пациента с бронхиальной астмой в клинической практике врача педиатра //Аллергология и иммунология в педиатрии. 2023. № 2. С. 60-62.) DOI: 10.53529/2500-1175-2023-2-60-62
Trusova OV. The Efficacy of Sublingual Allergen-specific Immunotherapy with House Dust Mite Allergens in Children with Asthma. Practical Pulmonology. 2021; 2: 9-16. Russian (Трусова О.В. Эффективность сублингвальной аллергенспецифической иммунотерапии с аллергенами клещей домашней пыли при бронхиальной астме у детей //Практическая пульмонология. 2021. № 2. С. 9-16.) DOI: 10.24412/2409-6636-2021-12687
Chan AW, Luk WP, Fung LH, Lee TH. The effectiveness of sublingual immunotherapy for house dust mite-induced allergic rhinitis and its co-morbid conditions. Immunotherapy. 2019; 11(16): 1387-1397. DOI: 10.2217/imt-2019-0093
Butz AM, Bollinger ME, Ogborn J, Morphew T, Mudd SS, Kub JE, et al. Children with poorly controlled asthma: Randomized controlled trial of a home‐based environmental control intervention. Pediatr Pulmonol. 2019; 54(3): 245-256. DOI: 10.1002 / ppul.24239
Ermakova MK, Matveeva LP, Naidenkina SN. Errors in the diagnosis and therapy of bronchial asthma in children. Russian Bulletin of Perinatology and Pediatrics. 2023; 68(4): 102-107. Russian (Ермакова М.К., Матвеева Л.П., Найденкина С.Н. Ошибки диагностики и терапии бронхиальной астмы у детей //Российский вестник перинатологии и педиатрии. 2023. Т. 68, № 4. С. 102-107.) DOI: 10.21508/1027-4065-2023-68-4-102-XX
Avdeev SN, Voznesenskiy NA, Boldina MV, Van`kova EI, Zajkova-Khelimskaya IV, Ignatova GL, et al. Overuse of short-acting β2-agonists in the Russian population with asthma: the persisting threat. Pul’monologiya. 2022; 32(5): 661-669. Russian (Авдеев С.Н., Вознесенский Н.А., Болдина М.В., Ванькова Е.И., Зайкова-Хелимская И.В., Игнатова Г.Л., и др. Избыточное использование β2-агонистов короткого действия у больных бронхиальной астмой в России: угроза сохраняется //Пульмонология. 2022. Т. 32, № 5. С. 661-669.) DOI: 10.18093/0869-0189-2022-32-5-661-669